Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 51, Issue 1, Pages 237-242Publisher
SPRINGER
DOI: 10.1007/s11239-020-02219-z
Keywords
COVID-19; Aortic thrombi; Severe pneumonia
Ask authors/readers for more resources
COVID-19 may predispose patients to both venous and arterial thromboembolism due to an exaggerated immune response to the virus, especially in severe cases. A series of three cases of aortic thrombi diagnosed by CT angiography in patients with confirmed SARS-CoV-2 infection further highlights the pro-coagulant nature of COVID-19.
Coronavirus disease 2019 (COVID-19) could predispose to both venous and arterial thromboembolism, in an exaggerated immune response to the virus, especially in severe patients. Even though aortic clots are a rare entity, the pro-coagulant nature of COVID-19 is associated with thrombosis in atypical locations and should be considered in patients with severe abnormalities in coagulation parameters. We describe a series of three cases of aortic thrombi diagnosed by computerized tomography (CT) angiography in patients with confirmed SARS-CoV-2 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available